National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 18659-18660 [2017-07935]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 75 / Thursday, April 20, 2017 / Notices
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID CLINICAL TRIAL
PLANNING GRANT (R34).
Date: May 18, 2017.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Jay R. Radke, Ph.D., AIDS
Review Branch, Scientific Review Program,
Division of Extramural Activities, Room
#3G11B, National Institutes of Health, NIAID,
5601 Fishers Lane MSC–9823, Bethesda, MD
20892–9823, (240) 669–5046, jay.radke@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Peer Review Meeting.
Date: May 18, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Kelly Y. Poe, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3F40B, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–669–5036,
poeky@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07934 Filed 4–19–17; 8:45 am]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council
Date: June 15, 2017
Open: 8:30 a.m. to 1:00 p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
the staff of the Institute and discussions
concerning Institute programs.
Place: National Eye Institute, NIH, 5635
Fishers Lane, Terrace Level Conference
Rooms, Rockville, MD 20852.
Closed: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Eye Institute, NIH, 5635
Fishers Lane, Terrace Level Conference
Rooms, Rockville, MD 20852.
Contact Person: Paul A. Sheehy, Ph.D.,
Executive Secretary, Division of Extramural,
Research National Eye Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
12300, Bethesda, MD 20892, 301–451–2020,
ps32h@nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: April 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07932 Filed 4–19–17; 8:45 am]
National Eye Institute; Notice of
Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
VerDate Sep<11>2014
17:27 Apr 19, 2017
Jkt 241001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
18659
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Loan
Repayment Program (LRP) Applications.
Date: April 26, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health 5635
Fishers Lane, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Brian Hoshaw, Ph.D.,
Scientific Review Officer National Eye
Institute National Institutes of Health,
Division of Extramural Research 5635 Fishers
Lane, Suite 1300, Rockville, MD 20892, 301–
451–2020, hoshawb@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: April 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07933 Filed 4–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
E:\FR\FM\20APN1.SGM
20APN1
18660
Federal Register / Vol. 82, No. 75 / Thursday, April 20, 2017 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Clinical Trial
Implementation Cooperative Agreement
(U01).
Date: May 11, 2017.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Jay R. Radke, Ph.D., AIDS
Review Branch, Scientific Review Program,
Division of Extramural Activities, Room
#3G11B, National Institutes of Health, NIAID,
5601 Fishers Lane MSC–9823, Bethesda, MD
20892–9823, (240) 669–5046, jay.radke@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07935 Filed 4–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director Amended; Notice
of Meeting
Notice is hereby given of a change in
the meeting of the NIH Clinical Center
Research Hospital Board, on Friday,
April 28, 2017, 8:30 a.m. to April 28,
2017: 5:00 p.m., National Institutes of
Health, Building 31, Conference Room
6C6, Bethesda, Maryland 20892 which
was published in the Federal Register
on Thursday, April 13, 2017, 82 FR
17847.
The meeting notice is amended to
change the time of the closed session.
The closed session that was previously
announced being held from 3:20 p.m. to
5:00 p.m. to discuss the identification of
candidates for leadership roles will now
be held from 11:45 a.m. to 12:30 p.m.
Dated: April 14, 2017.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07939 Filed 4–19–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the infor
mation shall have practical utility; (b)
the accuracy of the agency’s estimate of
the burden of the proposed collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: State Targeted
Response to the Opioid Crisis Grant
Program Reports—NEW
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is authorized under Section
1003 of the 21st Century Cures Act, as
amended, to support a grant program,
for up to 2 years, that addresses the
supplemental activities pertaining to
opioids currently undertaken by the
state agency or territory and will
support a comprehensive response to
the opioid epidemic. The State Targeted
Response to the Opioid Crisis Grant
(Opioid STR) program addresses
Healthy People 2020, Substance Abuse
Topic Area HP 2020–SA.The primary
purpose of Opioid STR is to address the
opioid crisis by increasing access to
treatment, reducing unmet treatment
need, and reducing opioid overdose
related deaths through the provision of
prevention, treatment and recovery
activities for opioid use disorder (OUD)
(including prescription opioids as well
as illicit drugs such as heroin).
There will be up to 59 (states and
jurisdictions) award recipients in this
program. All funded states and
jurisdictions will be asked to report on
their implementation and performance
through an online data collection
system. Award recipients will report
performance on the following measures
specific to this program: Number of
people who receive OUD treatment,
number of people who receive OUD
recovery services, number of providers
implementing medication-assisted
treatment, and the number of OUD
prevention and treatment providers
trained, to include NPs, PAs, as well as
physicians, nurses, counselors, social
workers, case managers, etc.
This information will be collected at
the mid-point and conclusion of each
grant award year.
Additionally, each award recipient
will describe the purposes for which the
grant funds received were expended and
the activities under the program, and
the ultimate recipients of amounts
provided to the grantee in the grants.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
ANNUALIZED ESTIMATED BURDEN HOURS FOR THE PROGRESS REPORT
Respondent
Number of
respondents
Number of
responses
per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
State and Jurisdictions .........................................................
57
2
114
8.0
912
VerDate Sep<11>2014
17:27 Apr 19, 2017
Jkt 241001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 82, Number 75 (Thursday, April 20, 2017)]
[Notices]
[Pages 18659-18660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07935]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
[[Page 18660]]
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel NIAID Clinical Trial Implementation
Cooperative Agreement (U01).
Date: May 11, 2017.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Jay R. Radke, Ph.D., AIDS Review Branch,
Scientific Review Program, Division of Extramural Activities, Room
#3G11B, National Institutes of Health, NIAID, 5601 Fishers Lane MSC-
9823, Bethesda, MD 20892-9823, (240) 669-5046, jay.radke@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07935 Filed 4-19-17; 8:45 am]
BILLING CODE 4140-01-P
